Based on the analysis of scRNA-seq and bulk RNA-seq data, we built and validated a cancer fibroblast-related risk signature consisting of five genes (BGN, LUM, CCL19, CEBPD, and ID3) that may be utilized as an independent prognostic indicator for breast cancer patients. The gene discussed is CEBPD; the disease is cancer.